A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation studyJesse J. Swen, Roelof Bosch, Kathrin Blagec et al.|The Lancet|2023Cited by 508
A Review of the Important Role of CYP2D6 in PharmacogenomicsChristopher E. Taylor, Richard M. Turner|Genes|2020Cited by 302